2m 2m 2m 2m 2m 2m 2m
HealthLynked (HLYK)
OTC
$2.99+$0.64 (+27.42%)
Price as of Jun 03, 2026- $6.7MMarket Cap
- 54.12%1-Year Change
- Medical Care FacilitiesIndustry
HealthLynked (HLYK)
$2.99+$0.64 (+27.42%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.0M -30.28% | 2.9M -49.81% | 5.7M -2.32% | 5.9M -36.31% | |
Cost of Revenue | 4.2M -45.63% | 7.7M -22.16% | 9.9M +807.44% | 1.1M -53.68% | |
Gross Profit | -2.2M -54.80% | -4.8M -356.88% | 1.9M -60.71% | 4.8M -30.35% | |
Sales and Marketing Expense | 2.0M -33.02% | 3.0M -16.13% | 3.6M -20.84% | 4.6M -7.14% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 101,871 -64.00% | 282,950 -19.62% | 352,027 -57.56% | 829,481 +0.22% | |
Total Operating Expenses | 7.2M -41.48% | 12.3M -21.79% | 15.7M +8.16% | 14.5M +1.94% | |
Operating Profit | -3.3M -29.87% | -4.7M +12.67% | -4.2M -52.06% | -8.7M +71.70% | |
Interest Income | 2,316 -91.20% | 26,316 +22.23% | 21,530 +231.08% | 6,503 0.00% | |
Interest Expense | -216,134 +28.54% | -168,144 +100.62% | -83,812 +644.07% | -11,264 +41.22% | |
Interest Income and Expense and Net | -213,818 +50.76% | -141,828 +127.72% | -62,282 +1,208.17% | -4,761 +223.22% | |
Total Nonoperating Income and Expense | -1.2M -19.73% | -1.5M -370.35% | 537,760 +2,456.01% | -22,825 -99.57% | |
Income before Taxes | -3.3M -46.50% | -6.1M +69.66% | -3.6M -55.20% | -8.1M -22.52% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | -618,208 -835.01% | 84,109 -73.71% | 319,958 -88.35% | 2.7M N/A | |
Net Income | -3.3M -46.50% | -6.1M +505.76% | -1.0M -88.52% | -8.8M -15.34% | |
Net Income from Continuing Operations Applicable to Common | -3.3M -46.50% | -6.1M +69.66% | -3.6M -55.20% | -8.1M -25.07% | |
Basic EPS and Net Income | -1.16 +5,700.00% | -0.02 N/A | 0.00 +100.00% | -0.04 -20.00% | |
Diluted EPS and Net Income | -1.16 +5,700.00% | -0.02 N/A | 0.00 +100.00% | -0.04 -20.00% | |
Basic Weighted Average Shares | 2.8M -98.99% | 281.5M +7.09% | 262.9M +8.00% | 243.4M +6.83% | |
Diluted Weighted Average Shares | 2.8M -98.99% | 281.5M +7.09% | 262.9M +8.00% | 243.4M +6.83% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 37,136 -51.29% | 76,241 -69.16% | 247,222 +299.45% | 61,891 -98.12% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 37,136 -51.29% | 76,241 -69.16% | 247,222 +299.45% | 61,891 -98.12% | |
Total Current Assets | 1.6M -5.46% | 1.6M +150.12% | 656,160 -69.40% | 2.1M -41.25% | |
Accumulated Depreciation | 728,710 +14.79% | 634,839 +21.84% | 521,062 +31.19% | 397,194 +40.10% | |
Property and Plant and Equipment and Net | 74,705 -57.69% | 176,576 -39.27% | 290,755 -29.62% | 413,123 +17.87% | |
Total Long-Term Assets | 74,705 -57.69% | 176,576 -39.27% | 290,755 -29.62% | 413,123 +17.87% | |
Total Assets | 1.7M -23.42% | 2.2M -48.06% | 4.3M -6.56% | 4.6M -57.17% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 5.5M +72.24% | 3.2M +110.27% | 1.5M +423.85% | 291,650 +376.16% | |
Total Current Liabilities | 7.0M +49.54% | 4.7M +94.44% | 2.4M -30.58% | 3.5M +81.17% | |
Total Long-Term Debt | 5.5M +120.81% | 2.5M +413.12% | 489,476 +987.72% | 45,000 -91.84% | |
Total Long-Term Liabilities | 922 -99.40% | 153,592 -74.96% | 613,386 +152.08% | 243,330 +1.72% | |
Total Liabilities | 7.5M +39.46% | 5.4M +54.00% | 3.5M -18.54% | 4.3M +22.22% | |
Retained Earnings | -50.5M +4.93% | -48.2M +14.59% | -42.0M +2.47% | -41.0M +27.37% | |
Total Stockholders Equity | -5.8M +84.13% | -3.1M -488.85% | 804,730 +155.92% | 314,450 -95.63% | |
Total Shares Outstanding | 2.8M -99.00% | 281.9M +2.17% | 276.0M +7.82% | 255.9M +7.59% | |
Cash Flow | |||||
Cash from Operating Activities | -1.7M -50.95% | -3.5M -15.70% | -4.1M -5.00% | -4.4M +15.73% | |
Capital Expenditures | N/A N/A | 2,598 +73.20% | 1,500 -93.63% | 23,564 +22.41% | |
Cash from Investing Activities | 125,000 -70.41% | 422,402 -87.95% | 3.5M +743.62% | -544,750 +59.58% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.5M -46.58% | 2.9M +251.99% | 824,087 -50.89% | 1.7M -76.83% | |
Financials Ratio | |||||
Gross Margin | -108.66% -35.17% | -167.60% +131.01% | -72.55% -189.10% | 81.43% +9.36% | |
Operating Margin | -163.80% +0.58% | -162.86% +124.47% | -72.55% -50.92% | -147.82% +169.58% | |
Return on Assets | -167.13% -11.37% | -188.57% +725.37% | -22.85% -80.21% | -115.42% +3.76% | |
Return on Equity | 73.79% -86.01% | 527.56% +391.66% | -180.88% -22.87% | -234.51% -3.67% | |
Revenue Growth | -30.28% -39.21% | -49.81% +2,048.29% | -2.32% -93.61% | -36.31% -172.66% | |
Current Ratio | 0.22 -36.78% | 0.35 +28.64% | 0.27 -55.93% | 0.62 -67.57% | |
Cash Ratio | 0.005 -67.48% | 0.02 -84.10% | 0.10 +475.84% | 0.02 -98.96% | |
Debt-to-Equity Ratio | -1.92 +5.11% | -1.83 -172.97% | 2.51 +134.15% | 1.07 +1,159.53% | |
Debt-to-Assets Ratio | 6.51 +152.74% | 2.58 +446.36% | 0.47 +541.22% | 0.07 +28.27% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow